TipRanks
COSMO Pharmaceuticals N.V. (CH:CMHC)
:CMHC
Switzerland Market
CMHC
COSMO Pharmaceuticals N.V.
RESEARCH TOOLSreports
Want to see CH:CMHC full AI Analyst Report?

COSMO Pharmaceuticals N.V. (CMHC) Income Statement

32 Followers

COSMO Pharmaceuticals N.V. Income Statement

Last quarter (Q2 2026), COSMO Pharmaceuticals N.V.'s total revenue was €50.15M, a decrease of -63.19% from the same quarter last year. In Q2, COSMO Pharmaceuticals N.V.'s net income was €-4.74M. See COSMO Pharmaceuticals N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 104.85M€ 266.79M€ 92.78M€ 102.09M€ 65.07M
Gross Profit
€ 48.78M€ 246.92M€ 53.44M€ 83.33M€ 49.93M
Operating Expenses
€ 59.27M€ 98.04M€ 47.29M€ 55.27M€ 21.00M
Depreciation and Amortization
€ 12.76M€ 12.29M€ 11.85M€ 13.86M€ 7.37M
EBITDA
€ 2.27M€ 165.71M€ 18.00M€ 47.49M€ 18.47M
Operating Income
€ -10.48M€ 148.88M€ 6.15M€ 28.06M€ 11.10M
Other Income/Expenses
€ 9.56M€ 4.49M€ -4.61M€ -3.58M€ 12.90M
Pretax Income
€ -924.00K€ 153.37M€ 1.53M€ 24.47M€ 24.00M
Net Income
€ -3.63M€ 133.24M€ -4.93M€ 17.23M€ 21.67M
Per Share Metrics
Basic EPS
€ -0.23€ 8.15€ -0.31€ 1.05€ 1.29
Diluted EPS
€ -0.23€ 8.12€ -0.31€ 1.05€ 1.28
Weighted Average Shares Outstanding
 15.97M 16.36M 16.11M 16.43M 16.84M
Weighted Average Shares Outstanding (Diluted)
 15.97M 16.42M 16.11M 16.43M 16.90M
Currency in EUR

COSMO Pharmaceuticals N.V. Earnings and Revenue History